Hypera Pharma
Celio Jose Silva Santos has extensive experience in financial planning and analysis, currently serving as Coordenador de Planejamento Financeiro (FP&A) at Hypera since October 2021, where responsibilities include financial modeling, analysis of margins and profitability, and process improvements. Previous roles at Roche encompassed senior analyst positions focused on P&L management, forecasting, and supporting strategic planning, with additional experience at GOL Linhas Aéreas Inteligentes in financial reporting and operational performance monitoring. Celio's career began at Instituto Santista de Hemodinâmica, progressing through various financial analysis roles. Education includes a postgraduate specialization in Finance from Insper and a Bachelor’s degree in Business Administration from Pontifícia Universidade Católica de São Paulo, complemented by additional finance and English studies.
This person is not in any teams
This person is not in any offices
Hypera Pharma
5 followers
Hypera SA, formerly Hypermarcas SA, is a Brazil-based company engaged in the pharmaceuticals sector. The Company's major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa.